-transparent.png){kind=logo}
Thyrotropin-releasing hormone (TRH) was administered iv to 10 patients with severe liver disease and 10 control subjects. Injection of 400 microgram TRH as a bolus induced in 7 out of 10 patients a clear-cut GH rise (larger than or equal 10 ng/ml) occurring 15-120 min after the injection, and no effect on GH levels in controls. Mean baseline GH levels wre higher in patients than in controls. An exaggerated and sustained PRL rise was present after TRH in the subjects with liver disease, whose mean baseline plasma PRL levels were within normal range.
Related Publications
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
January 1981,
The Journal of nuclear medicine and allied sciences,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
September 1973,
The Journal of clinical endocrinology and metabolism,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
February 1987,
Biological psychiatry,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
December 1977,
Journal of dairy science,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
June 1985,
Endocrinologia japonica,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
January 1982,
Psychoneuroendocrinology,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
March 1989,
The Journal of clinical endocrinology and metabolism,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
March 1976,
Cancer,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
January 1979,
Currents in alcoholism,
A E Panerai, and
F Salerno, and
M Manneschi, and
D Cocchi, and
E E Müller
September 1980,
Il Farmaco; edizione pratica,
